Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/5096
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKaratas, H.-
dc.contributor.authorYalcin, A.N.-
dc.contributor.authorTurgut, Hüseyin-
dc.contributor.authorÇetin, Banu-
dc.date.accessioned2019-08-16T11:41:19Z
dc.date.available2019-08-16T11:41:19Z
dc.date.issued2004-
dc.identifier.issn1124-9390-
dc.identifier.urihttps://hdl.handle.net/11499/5096-
dc.description.abstractA prospective study was designed in order to determine to what extent antibiotics are used in treating community-acquired infections and their costs. Between February and July 2001 a total of 43,011 prescriptions from a representative sample of pharmacies in the city of Denizli (Turkey) were evaluated during the study period. Antibiotics accounted for 16.4% of total prescriptions and 30.8% of the market value of drugs. Penicillins (49.7%), followed by cephalosporins (17.3%), macrolides (9.5%), and aminoglycosides (7.6%) were the most frequently prescribed antibiotics during the study period. The economic burden of antibiotic usage in the community is found higher than in developed countries. In order to reduce this cost the proper use of antibiotics is a matter of urgency.en_US
dc.language.isoenen_US
dc.relation.ispartofInfezioni in Medicinaen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntibioticsen_US
dc.subjectCosten_US
dc.subjectPharmacoeconomicsen_US
dc.subjectaminoglycoside antibiotic agenten_US
dc.subjectamoxicillin plus clavulanic aciden_US
dc.subjectantibiotic agenten_US
dc.subjectazithromycinen_US
dc.subjectcefacloren_US
dc.subjectcefazolinen_US
dc.subjectcefuroximeen_US
dc.subjectcephalosporin derivativeen_US
dc.subjectclarithromycinen_US
dc.subjectlincosamideen_US
dc.subjectmacrolideen_US
dc.subjectpenicillin derivativeen_US
dc.subjectquinoline derived antiinfective agenten_US
dc.subjectsulfonamideen_US
dc.subjectsultamicillinen_US
dc.subjectantibiotic therapyen_US
dc.subjectarticleen_US
dc.subjectbacterial infectionen_US
dc.subjectcommunity careen_US
dc.subjectdrug costen_US
dc.subjectdrug formulationen_US
dc.subjectdrug marketingen_US
dc.subjecteconomic aspecten_US
dc.subjecthealth care costen_US
dc.subjecthumanen_US
dc.subjectmajor clinical studyen_US
dc.subjectpharmacyen_US
dc.subjectprescriptionen_US
dc.subjectprospective studyen_US
dc.subjecttableten_US
dc.subjectTurkey (republic)en_US
dc.subjectAminoglycosidesen_US
dc.subjectAnti-Bacterial Agentsen_US
dc.subjectCephalosporinsen_US
dc.subjectDeveloping Countriesen_US
dc.subjectDrug Costsen_US
dc.subjectDrug Prescriptionsen_US
dc.subjectDrug Utilizationen_US
dc.subjectMacrolidesen_US
dc.subjectPenicillinsen_US
dc.subjectPharmaciesen_US
dc.subjectPrescriptions, Drugen_US
dc.subjectProspective Studiesen_US
dc.subjectQuinolonesen_US
dc.subjectTurkeyen_US
dc.titleAntibiotic usage and costs in the communityen_US
dc.typeArticleen_US
dc.identifier.volume12en_US
dc.identifier.issue2en_US
dc.identifier.startpage132
dc.identifier.startpage132en_US
dc.identifier.endpage135en_US
dc.authorid0000-0003-4270-3997-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-3242739293en_US
dc.identifier.scopusqualityQ4-
dc.ownerPamukkale_University-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.cerifentitytypePublications-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept10.01. Environmental Engineering-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

3
checked on Dec 14, 2024

Page view(s)

48
checked on Aug 24, 2024

Google ScholarTM

Check





Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.